Published in Gene Therapy Weekly, November 9th, 2000
"An alternative strategy has been the use of antiviral genes that are delivered to uninfected cells as either RNA or DNA and provide intercellular protection from HIV-1," stated Y. Habu and colleagues from the Chiba Institute of Technology, Narashino. "Antiviral genes include those encoding antisense molecules, ribozymes, transdominant proteins, and intracellular antibodies."
Habu et al. presented data from their study at the XIV International Roundtable, Nucleosides, Nucleotides, and their Biological Applications, held September 10-14, 2000, in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.